Modulation of glycogen synthase kinase-3β following TRAIL combinatorial treatment in cancer cells

Glycogen Synthase Kinase-3β (GSK3β) is a serine/threonine kinase, known to regulate various cellular processes including proliferation, differentiation, survival, apoptosis as well as TRAIL-resistance. Thus pathways that can modulate GSK3β axis are important targets for cancer drug development. Our...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Santha, Sreevidya, Davaakhuu, Gantulga, Basu, Aninda, Ke, Rong, Das, Subhasis, Rana, Ajay, Rana, Basabi
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5341845/
https://ncbi.nlm.nih.gov/pubmed/27602497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11834
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items